调强放疗中在淋巴结阳性颈部保留同侧腮腺的危害:区域复发风险的空间分析
连续305例淋巴结阳性头颈鳞癌患者接受调强放疗,前139例在计划中刻意将同侧腮腺设为避让结构,后166例未刻意保留同侧腮腺。刻意保留组2年总生存77%对86%(P=.01)、2年区域控制76%对90%(P<.001),且空间分析显示该组边缘失败和真性遗漏发生率显著更高。
要点
- 刻意保留同侧腮腺组2年区域控制76%,未刻意保留组90%(P<.001)。
- 刻意保留同侧腮腺组2年总生存77%,未刻意保留组86%(P=.01)。
- 空间分析显示刻意保留组边缘失败和真性遗漏发生率显著更高。
核心结论
- 作者呼吁在使用调强放疗保留患侧颈部病变同侧腮腺时需谨慎。
- 研究显示刻意保留同侧腮腺组区域失败显著更多,作者强调需仔细选择患者并考虑影响同侧颈部复发可能性的临床和病理因素。
研究设计与样本
- 连续队列研究,共305例淋巴结阳性头颈鳞癌患者接受调强放疗。
- 前139例在计划中将同侧腮腺勾画并刻意设为避让结构,后166例未刻意保留同侧腮腺。
主要发现
- 全组2年总生存、局部区域控制、无远处转移生存估计分别为84%、73%、87%。
- 刻意保留同侧腮腺组与未刻意保留组2年总生存分别为77%和86%(P=.01)。
- 刻意保留同侧腮腺组与未刻意保留组2年区域控制分别为76%和90%(P<.001)。
- 两组均观察到同侧颈部淋巴结负荷增加与区域失败可能性之间存在趋势。
- 空间评估显示刻意保留同侧腮腺组边缘失败和真性遗漏发生率显著更高。
临床怎么用
- 作者认为使用调强放疗保留患侧颈部病变同侧腮腺时需谨慎。
- 作者建议仔细选择患者并考虑影响同侧颈部复发可能性的临床和病理因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The practice of deliberately sparing the ipsilateral parotid gland with intensity modulated radiation therapy (IMRT) in patients with node-positive head and neck cancer is controversial. We sought to compare the clinical outcomes among consecutive cohorts of patients with head and neck cancer who were treated with differing strategies to spare the parotid gland that is ipsilateral to the involved neck using IMRT. METHODS AND MATERIALS: A total of 305 patients were treated with IMRT for node-positive squamous cell carcinoma of the head and neck. The first 139 patients were treated with IMRT whereby the ipsilateral parotid gland was delineated and intentionally designated as an avoidance structure during planning. The subsequent 166 patients were treated by IMRT without the deliberate sparing of the ipsilateral parotid gland. RESULTS: The 2-year estimates of overall survival, local-regional control, and distant metastasis-free survival were 84%, 73%, and 87%, respectively. The 2-year estimates of overall survival were 77% and 86% among patients who were treated by IMRT with and without the sparing of the ipsilateral parotid gland, respectively (P = .01). The respective rates of 2-year regional control were 76% and 90% (P < .001). A trend was observed between increased nodal burden in the ipsilateral cervical neck and the likelihood of regional failure for both groups. A spatial evaluation revealed a significantly higher incidence of marginal failures and true misses in the cohort of patients who underwent IMRT with the sparing of the ipsilateral parotid gland. CONCLUSION: Caution is urged when using IMRT to spare patients' parotid gland on the involved side of neck disease. Our study showed a significantly higher preponderance of regional failure, which highlights the need for careful patient selection and consideration of clinical and pathological factors that influence the likelihood of disease recurrence in the ipsilateral neck.
引用
- Chen AM, Yoshizaki T, Wang PC, et al. Hazards of sparing the ipsilateral parotid gland in the node-positive neck with intensity modulated radiation therapy: Spatial analysis of regional recurrence risk. Adv Radiat Oncol. 2017. PMID: 29904734. doi:10.1016/j.adro.2017.12.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。